Tilray, Inc. (NASDAQ: TLRY) (TSE: TLRY) is a pharmaceutical, cannabis-lifestyle and consumer packaged goods company. It is focused on medical cannabis research, cultivation, processing and distribution of cannabis products across the world. The company’s products include dried cannabis and cannabis extracts. Based out of New York, Tilray also has operations in Canada, Australia, New Zealand, and Latin America, with growing facilities in Germany and Portugal. TLRY stock closed 1.6% up on Tuesday. Further, it was trading 0.5% higher in the pre-market session on Wednesday. Q3 Results Earlier this month, the company reported financial results for the fiscal third quarter ended February 28.
https://www.tipranks.com/news/article/apart-from-stock-price-whats-up-with-tilray?utm_source=advfn.com&utm_medium=referral